Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposomes versus standard bupivacaine with pulsed radiofrequency for herpes zoster-associated pain
ChiCTR2500104193Phase 4Not yet recruiting
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine in herpes zoster (HZ) and postherpetic neuralgia (PHN) (2 arms), sponsored by Ningbo Medical Centre Lihuili Hospital. Primary endpoint: VAS score. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
herpes zoster (HZ)postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ChiCTR2500104193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104193.